Literature DB >> 2849338

Acidity potentiates bronchoconstriction induced by hypoosmolar aerosols.

J R Balmes1, J M Fine, D Christian, T Gordon, D Sheppard.   

Abstract

Naturally occurring fogs are usually hypoosmolar with respect to body fluids and can be quite acidic. Because both hypoosmolarity and acidity can cause bronchoconstriction, we studied whether there was a positive interaction between these stimuli in 12 subjects with asthma. We administered the following aerosols: hypoosmolar saline (30 mOsm) at pH 5.5, 3 hypoosmolar acids (0.005 M H2SO4, 0.01 M HNO3 and a 1:1 mixture of 0.005 M H2SO4 and 0.01 M HNO3, all 30 mOsm) at pH 2, and isoosmolar 0.005 M H2SO4 (300 mOsm) at pH 2. Each aerosol was administered on a separate day and was inhaled through a mouthpiece during tidal breathing. Specific airway resistance (SRaw) was measured before and after the subjects inhaled aerosols delivered at as much as 5 doubling nebulizer outputs. For each aerosol challenge, an output-response curve was generated, and the nebulizer output required to increase SRaw by 100% above baseline (PO100) was calculated. Mean values of PO100 were significantly lower for each of the hypoosmolar acids than for hypoosmolar saline (1.65 + 0.43 g/min [mean + SEM] for saline compared with 0.95 + 0.11, 1.05 + 0.20, and 0.90 + 0.14 for H2SO4, HNO3, and a 1:1 mixture of the two; all p values less than 0.025). Mean values of PO100 did not differ among the 3 acids studied. For 7 of 12 subjects, all 3 acids caused a leftward shift in the output-response curve from the curve generated for hypoosmolar saline aerosol. Isoosmolar H2SO4 did not increase SRaw by 100% in any subjects, even at the maximal nebulizer output that delivered a concentration of H2SO4 in excess of 40 mg/m3.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2849338     DOI: 10.1164/ajrccm/138.1.35

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  6 in total

Review 1.  Airway acidification and gastroesophageal reflux.

Authors:  John F Hunt; Benjamin Gaston
Journal:  Curr Allergy Asthma Rep       Date:  2008-03       Impact factor: 4.806

2.  Osmolality and pH of anti-asthmatic drug solutions.

Authors:  K N Desager; H P Van Bever; W J Stevens
Journal:  Agents Actions       Date:  1990-11

3.  In vitro and in vivo effects of ribavirin on human respiratory epithelium.

Authors:  L Y Han; R Wilson; S Slater; A Rutman; R C Read; N J Snell; P J Cole
Journal:  Thorax       Date:  1990-02       Impact factor: 9.139

4.  Hypoxaemia after nebulised salbutamol in wheezy infants: the importance of aerosol acidity.

Authors:  J Seidenberg; Y Mir; H von der Hardt
Journal:  Arch Dis Child       Date:  1991-06       Impact factor: 3.791

Review 5.  Essentials in saline pharmacology for nasal or respiratory hygiene in times of COVID-19.

Authors:  Suzy Huijghebaert; Levi Hoste; Guido Vanham
Journal:  Eur J Clin Pharmacol       Date:  2021-03-27       Impact factor: 2.953

6.  Physicochemical compatibility of fluticasone-17- propionate nebulizer suspension with ipratropium and albuterol nebulizer solutions.

Authors:  Wolfgang Kamin; Astrid Schwabe; Irene Krämer
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.